AIM-listed Advanced Medical Solutions reported that group revenue rose 53 per cent to 52.6m pounds in the year ended December 31st, supported by strong performance in its own brand business, Branded Direct.
[6 Mar '13]Advanced Medical Solutions: Investec takes target price from 68p to 74p and maintains a buy recommendation.
[6 Mar '13]Admiral Group: Investec takes target price from 570p to 582p, but still recommends selling.
[19 Feb '13]Advanced Medical Solutions has revealed its annual profits will be at the 'lower end' of market expectations.
[13 Dec '12]Advanced Medical Solutions: Investec reduces target price from 93p to 68p and downgrades from buy to hold. Numis downgrades to hold, while maintaining the target price at 165p. Canaccord Genuity moves target price from 93p to 90p and retains a buy recommendation.
[13 Dec '12]In the Financial Times, the Lex column urges caution on the apparent temptation of Nokia. The stock has collapsed 92pc in the last five years, hammered by the emergence of Apple's iPhone. In the last month though the stock has recovered somewhat, buoyed by Apple's victory in a US patent case against Samsung. Nokia doesn't appear to face the same pressure on its operating system as its competitors because it doesn't look or feel like iOS. On the other hand its latest offering,
[6 Sep '12]Wounds treatment firm Advanced Medical Solutions was in demand after it posted a jump in profits and raised its dividend.
[5 Sep '12]888, Advanced Medical, Astra, Bunzl, Cairn, Centrica, G4S, Immunodiagnostic, Lamprell, M&S, Meggitt, Morrison, Petrofac, Reckitt, Reed Elsevier, Regus, Shire, SEE, Travis Perkins
[29 Aug '12]